Koa Shoji Holdings Co.,Ltd.
[KOA SHoji HOLDINGS CO., LTD.] Financial Summary 2026-08-07
Full-year results for the fiscal year ending June 2026 and earnings guidance for the fiscal year ending June 2027 were disclosed. Revenue is expected to continue growth, with profit improvement driven by contributions from the active pharmaceutical ingredient segment and improved cost structure. Progress at the Zao Second Factory and developments in new product launches are also noted.
Key Figures
- Revenue 24,678 million yen (FY2026)
- Operating income 5,270 million yen (FY2026)
- Net income attributable to owners of parent 3?5.9? hundred million yen (estimates; unclear figures left as-is)
AI要約
Section heading
This document reports the results for the fiscal year ended June 2026 and the forecast for June 2027, focusing on revenue and profit trends, segment-specific dynamics, CAPEX/investment plans, and financial soundness. It highlights the contribution of the active pharmaceutical ingredient segment, the operating status of the Zao Second Factory, and cost management initiatives as key points.
Section 2 heading
Details the basis and assumptions for the 2027 forecast, growth drivers in the API segment, competitive environment in the pharmaceutical segment, and business strategy in the mid-to-long term (allocation among API, pharmaceutical products, and adjustments). Includes progress on medium-to-long-term financial targets and risk factors.
Revenue Trend
Operating income Trend
Segment revenue
Profit margin analysis
Forecast vs Actual
KOA SHoji Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
